During the weekly in-person, on-site visit required by Rule .1616(c)(2) of this Chapter, if not more frequently, the pharmacist-manager or assistant pharmacist-manager shall retrospectively perform a drug regimen review of all drugs dispensed by a nurse practitioner or physician assistant. During this review, the pharmacist-manager or assistant pharmacist-manager shall:

1. (1) review the appropriateness of the choice of medication(s) for each patient and the patient's therapeutic regimen, including choice of medication, dose, frequency, and route of administration;
2. (2) identify and resolve therapeutic duplication in each patient's medication regimen; and
3. (3) consider patient-specific medication contraindications.

History Note: Authority G.S. 90-18.1; 90-18.2; 90-85.6;
Eff. April 1, 1999;
Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. October 3, 2017;
Amended Eff. November 1, 2021.